Images
The journal ecancer.org echoes on the study performed by basic and clinical researchers at IDIBELL, VHIO, IDIBAPS and IRB Barcelona. Researchers have been able to recreate and characterise the process through which resistance to chemotherapy is acquired in orthotopic animal models of breast cancer.
Published by Stem Cell Reports, the study unveils the possibility of reversing this resistance after a period of rest from the treatment.
Link to ecancer.org
Other media mentions
Link to Jano
Link to El Confidencial
Link to Agencia SINC
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
